Sara A Corya

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study
    Sara A Corya
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 64:1349-56. 2003
  2. ncbi request reprint A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
    Sara A Corya
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Depress Anxiety 23:364-72. 2006
  3. ncbi request reprint A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Sara A Corya
    Lilly Research Laboratories, Indianapolis, Ind, USA
    J Clin Psychiatry 67:798-806. 2006
  4. pmc Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
    Holland C Detke
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
    BMC Psychiatry 10:43. 2010
  5. ncbi request reprint Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder
    Scott W Andersen
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 66:1468-76. 2005
  6. doi request reprint Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics
    Olawale Osuntokun
    Eli Lilly and Company, Indianapolis, IN 46285 6156, USA
    J Psychopharmacol 25:630-8. 2011
  7. ncbi request reprint Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression
    Paul E Keck
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    J Clin Psychiatry 66:611-6. 2005
  8. ncbi request reprint Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance
    Richard C Shelton
    Department of Psychiatry, Vanderbilt University, Nashville, TN 37212, USA
    J Clin Psychiatry 66:1289-97. 2005
  9. ncbi request reprint A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
    Michael E Thase
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    J Clin Psychiatry 68:224-36. 2007

Detail Information

Publications9

  1. ncbi request reprint Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study
    Sara A Corya
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 64:1349-56. 2003
    ..Long-term efficacy and safety were therefore investigated in a group of patients with major depressive disorder (MDD) with and without TRD...
  2. ncbi request reprint A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
    Sara A Corya
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Depress Anxiety 23:364-72. 2006
    ..e., olanzapine and fluoxetine), showed a rapid onset of antidepressant effect, and was effective in this TRD sample. At the study end point, OFC, fluoxetine, venlafaxine, and low-dose OFC all appeared to be similarly effective...
  3. ncbi request reprint A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Sara A Corya
    Lilly Research Laboratories, Indianapolis, Ind, USA
    J Clin Psychiatry 67:798-806. 2006
    ..The present analyses examined the efficacy and safety of longer term treatment with olanzapine-fluoxetine combination or olanzapine monotherapy in a 6-month open-label extension study...
  4. pmc Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
    Holland C Detke
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
    BMC Psychiatry 10:43. 2010
    ..During clinical trials, a post-injection syndrome characterized by signs of delirium and/or excessive sedation was identified in a small percentage of patients following injection with olanzapine LAI...
  5. ncbi request reprint Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder
    Scott W Andersen
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 66:1468-76. 2005
    ..g., age and gender) and correlates (e.g., cholesterol and glucose levels) of weight gain were investigated in OFC-treated patients with MDD...
  6. doi request reprint Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics
    Olawale Osuntokun
    Eli Lilly and Company, Indianapolis, IN 46285 6156, USA
    J Psychopharmacol 25:630-8. 2011
    ..04 mmol/L [N = 220; ME = 194], p = 0.048). The study concluded that there are changes with varying frequencies and magnitude in some metabolic parameters in patients treated with olanzapine compared with other atypical antipsychotics...
  7. ncbi request reprint Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression
    Paul E Keck
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    J Clin Psychiatry 66:611-6. 2005
    ..These subanalyses compare treatment-emergent mania rates in bipolar I depressed patients treated with olanzapine, placebo, or olanzapine/fluoxetine combination...
  8. ncbi request reprint Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance
    Richard C Shelton
    Department of Psychiatry, Vanderbilt University, Nashville, TN 37212, USA
    J Clin Psychiatry 66:1289-97. 2005
    ....
  9. ncbi request reprint A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
    Michael E Thase
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    J Clin Psychiatry 68:224-36. 2007
    ..Two parallel, 8-week double-blind studies compared olanzapine/fluoxetine combination, olanzapine, and fluoxetine in outpatients with treatment-resistant depression (TRD)...